PAVmed (PAVM) Asset Utilization Ratio (2022 - 2025)
PAVmed's (PAVM) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2025, down 97.62% year-on-year from 0.11 in Q4 2024, and up 267.62% quarter-over-quarter from 0.0 in Q3 2025.
PAVmed (PAVM) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
PAVmed's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio fell 97.62% year-over-year to 0.0 in Q4 2025; TTM through Dec 2025 was 0.0, a 97.62% decrease from a year earlier, with the FY2025 full-year figure at 0.0, down 96.93% from the prior year.
- Asset Utilization Ratio advanced to 0.0 in Q4 2025 per PAVM's latest filing, from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.11 in Q4 2024 and bottomed at 0.0 in Q3 2025.
- The 4-year median for Asset Utilization Ratio is 0.02 (2025), against an average of 0.04.
- Across the five-year window, Asset Utilization Ratio jumped 994.5% in 2023 and plunged 97.62% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then soared by 994.5% to 0.07 in 2023, then surged by 67.68% to 0.11 in 2024, then tumbled by 97.62% to 0.0 in 2025.
- Per Business Quant, the three latest PAVM Asset Utilization Ratio figures stand at 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.02 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.11 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |